David O. Irving

3.2k total citations
82 papers, 2.0k citations indexed

About

David O. Irving is a scholar working on Public Health, Environmental and Occupational Health, Hematology and Biochemistry. According to data from OpenAlex, David O. Irving has authored 82 papers receiving a total of 2.0k indexed citations (citations by other indexed papers that have themselves been cited), including 22 papers in Public Health, Environmental and Occupational Health, 19 papers in Hematology and 17 papers in Biochemistry. Recurrent topics in David O. Irving's work include Blood transfusion and management (17 papers), Blood donation and transfusion practices (16 papers) and Malaria Research and Control (13 papers). David O. Irving is often cited by papers focused on Blood transfusion and management (17 papers), Blood donation and transfusion practices (16 papers) and Malaria Research and Control (13 papers). David O. Irving collaborates with scholars based in Australia, United States and United Kingdom. David O. Irving's co-authors include Allan Saul, Robin F. Anders, David Pye, Graham V. Brown, Michael P. Alpers, Blaise Genton, Fadwa Al‐Yaman, Thomas A. Smith, Ingrid Felger and Inoni Betuela and has published in prestigious journals such as New England Journal of Medicine, JAMA and The Journal of Immunology.

In The Last Decade

David O. Irving

76 papers receiving 1.9k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
David O. Irving Australia 22 937 409 377 317 247 82 2.0k
Jonathan D. Kurtis United States 22 714 0.8× 453 1.1× 202 0.5× 209 0.7× 85 0.3× 52 1.7k
Tzong‐Hae Lee United States 30 655 0.7× 1.1k 2.7× 427 1.1× 562 1.8× 190 0.8× 74 3.6k
Gregory A. Foster United States 22 1.4k 1.5× 201 0.5× 119 0.3× 805 2.5× 87 0.4× 46 2.6k
Mars Stone United States 30 383 0.4× 151 0.4× 278 0.7× 382 1.2× 232 0.9× 117 2.2k
Mary H. McGinniss United States 20 1.4k 1.4× 953 2.3× 342 0.9× 290 0.9× 95 0.4× 52 2.6k
David E. Krysztof United States 20 846 0.9× 172 0.4× 107 0.3× 709 2.2× 107 0.4× 35 1.8k
Thomas R. Kreil Austria 30 564 0.6× 358 0.9× 488 1.3× 590 1.9× 40 0.2× 116 2.4k
Leslie H. Tobler United States 37 1.2k 1.3× 606 1.5× 226 0.6× 3.0k 9.3× 73 0.3× 74 5.2k
Gary E. Tegtmeier United States 19 189 0.2× 280 0.7× 308 0.8× 2.9k 9.3× 159 0.6× 42 4.1k
Bourèma Kouriba Mali 22 1.1k 1.2× 274 0.7× 125 0.3× 307 1.0× 9 0.0× 68 1.8k

Countries citing papers authored by David O. Irving

Since Specialization
Citations

This map shows the geographic impact of David O. Irving's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by David O. Irving with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites David O. Irving more than expected).

Fields of papers citing papers by David O. Irving

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by David O. Irving. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by David O. Irving. The network helps show where David O. Irving may publish in the future.

Co-authorship network of co-authors of David O. Irving

This figure shows the co-authorship network connecting the top 25 collaborators of David O. Irving. A scholar is included among the top collaborators of David O. Irving based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with David O. Irving. David O. Irving is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Reade, Michael C., Denese C. Marks, Belinda Howe, et al.. (2025). Cryopreserved vs Liquid-Stored Platelets for the Treatment of Surgical Bleeding. JAMA. 335(7). 600–600.
2.
3.
4.
Karki, Surendra, Katy Bell, Andrew Hayen, et al.. (2023). Regular high‐frequency whole blood donation and risk of cardiovascular disease in middle‐aged and older blood donors in Australia. Transfusion. 63(5). 1012–1022. 2 indexed citations
5.
Hirani, Rena, et al.. (2023). The prevalence of selected clinically significant red blood cell antigens among Australian blood donors. Pathology. 56(3). 398–403. 2 indexed citations
6.
Roulis, Eileen, Simon J. Craddock Lee, Natalie M. Pecheniuk, et al.. (2022). RBCeq: A robust and scalable algorithm for accurate genetic blood typing. EBioMedicine. 76. 103759–103759. 6 indexed citations
7.
Machalek, Dorothy A., John B. Carlin, Suellen Nicholson, et al.. (2022). Serological testing of blood donors to characterise the impact of COVID-19 in Melbourne, Australia, 2020. PLoS ONE. 17(7). e0265858–e0265858. 2 indexed citations
8.
Young, Pampee P., Lauren A. Crowder, Whitney R. Steele, et al.. (2021). Frequency of rare, serious donor reactions: International perspective. Transfusion. 61(6). 1780–1788. 8 indexed citations
9.
Gidding, Heather F., Dorothy A. Machalek, Alexandra Hendry, et al.. (2020). Seroprevalence of SARS-CoV-2-specific antibodies in Sydney, Australia following the first epidemic wave in 2020. The Medical Journal of Australia. 1. 5 indexed citations
10.
Reade, Michael C., Denese C. Marks, Rinaldo Bellomo, et al.. (2019). A randomized, controlled pilot clinical trial of cryopreserved platelets for perioperative surgical bleeding: the CLIP‐I trial (Editorial, p. 2759). Transfusion. 59(9). 2794–2804. 44 indexed citations
11.
Jegasothy, Edward, Jillian A. Patterson, Deborah Randall, et al.. (2018). Assessing the effect of risk factors on rates of obstetric transfusion over time using two methodological approaches. BMC Medical Research Methodology. 18(1). 139–139. 4 indexed citations
12.
Hirani, Rena, Melinda M. Dean, Zsolt J. Balogh, et al.. (2018). Donor white blood cell survival and cytokine profiles following red blood cell transfusion in Australian major trauma patients. Molecular Immunology. 103. 229–234. 4 indexed citations
13.
Kaukonen, Kirsi‐Maija, Michael Bailey, Cécile Aubron, et al.. (2014). A randomised controlled trial of standard transfusion versus fresher red blood cell use in intensive care (TRANSFUSE): protocol and statistical analysis plan. Critical Care and Resuscitation. 16(4). 255–261. 18 indexed citations
14.
Aubron, Cécile, Michael Bailey, Zoe McQuilten, et al.. (2014). Duration of red blood cells storage and outcome in critically ill patients. Journal of Critical Care. 29(3). 476.e1–476.e8. 17 indexed citations
15.
Szymlek‐Gay, Ewa A., Kun Young Lim, David O. Irving, et al.. (2013). The risk of zinc deficiency does not differ between premenopausal female Australian blood donors and non-donors : a cross-sectional study. Own your potential (DEAKIN). 2 indexed citations
16.
Pye, David, Kirsten Vandenberg, David O. Irving, et al.. (1997). Selection of an adjuvant for vaccination with the malaria antigen, MSA-2. Vaccine. 15(9). 1017–1023. 27 indexed citations
17.
Irving, David O., et al.. (1992). Epitopic Specificity of the Human Immune Response to the Invariant Region of a Polymorphic Plasmodium faciparum Merozoite Surface Antigen. Queensland's institutional digital repository (The University of Queensland). 2(3). 102–111. 1 indexed citations
18.
Collins, W E, Robin F. Anders, Trenton K. Ruebush, et al.. (1991). Immunization of Owl Monkeys with the Ring-Infected Erythrocyte Surface Antigen of Plasmodium falciparum. American Journal of Tropical Medicine and Hygiene. 44(1). 34–41. 30 indexed citations
19.
Irving, David O., et al.. (1987). Structure and expression of the knob-associated histidine-rich protein of Plasmodium falciparum. Molecular and Biochemical Parasitology. 26(1-2). 203–214. 26 indexed citations
20.
Irving, David O.. (1975). Hitler und seine Feldherren. Ullstein eBooks. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Jonathan D. Kurtis Breakdown of academic impact, for papers by Tzong‐Hae Lee Breakdown of academic impact, for papers by Gregory A. Foster Breakdown of academic impact, for papers by Mars Stone Breakdown of academic impact, for papers by Mary H. McGinniss Breakdown of academic impact, for papers by David E. Krysztof Breakdown of academic impact, for papers by Thomas R. Kreil Breakdown of academic impact, for papers by Leslie H. Tobler Breakdown of academic impact, for papers by Gary E. Tegtmeier Breakdown of academic impact, for papers by Bourèma Kouriba
Rankless by CCL
2026